Dyameo
Active in EUDAMEDFrancefrom SRN EUDAMED SRN FR-MF-000030350
- Devices
- 2
- Registrations
- EUDAMED
At a glance
Market reach
- European Union
- EUDAMED actor
What Dyameo makes
Dyameo manufactures handheld devices designed for rapid detection of cancer cells, including the TempoTouch and TempoProbe 11. These tools are intended for point-of-care use to identify abnormal cells during procedures such as biopsies or surgical excisions. The devices are engineered to provide immediate feedback to clinicians, aiding in real-time decision-making.
The company’s products fall under EU Class A medical devices and are registered in the EU’s eudamed database. The portfolio is governed by EU Medical Device Regulation (MDR) compliance requirements, ensuring adherence to safety and performance standards. The manufacturer is based in France.
Catalogue
- CE IVDR EUDAMED
- CE IVDR EUDAMED
Company details
- EUDAMED SRN
- FR-MF-000030350
- EU VAT number
- FR80828605386
- EUDAMED status
- Active
- EUDAMED registered name
- DYAMEO
- Registered address
- 7, rue Columbia, 87280, Limoges, France
- Website
- dyameo.com/
- fr.linkedin.com/company/dyameo
- [email protected]
- PRRC contact
- Cédric Enguehard
From the company website
Dyameo is a company specializing in medical devices. We developed a simple solution for instant detection of cancer cells.
Frequently asked questions
How many devices does DYAMEO have in the registry?
The registry currently lists 2 devices for DYAMEO. Devices recorded under merged duplicate company entries are counted once.
Which registries list DYAMEO's devices?
Among its 2 most recently registered devices, DYAMEO has devices listed in EUDAMED (2 devices).
What risk classes do DYAMEO's devices fall under?
Among its 2 most recently registered devices, the classes recorded for DYAMEO's devices are IVDR Class A. Each device page shows its own class and authorisation.
What are the newest devices from DYAMEO in the registry?
The most recently registered devices listed for DYAMEO include TempoTouch and TempoProbe 11.